2d:I[856015,["/_next/static/immutable/chunks/1xzisbplk9czp.js","/_next/static/immutable/chunks/3j2i1faptc_-9.js","/_next/static/immutable/chunks/0fma7nlq6immz.js","/_next/static/immutable/chunks/08tq8rmv423j5.js","/_next/static/immutable/chunks/1chr5wkk3j58k.js","/_next/static/immutable/chunks/37kmmh_zm4dov.js","/_next/static/immutable/chunks/311zvdjfxff-f.js","/_next/static/immutable/chunks/1a_hqhrsle_n_.js"],"default"] 2e:T50f8,

Summary Table

Feature	Detail
Risk Factors	Family history of anterior segment dysgenesis, consanguinity (autosomal recessive inheritance), known FOXE3 gene mutations in parents
Etiology	Failure of lens development (primary) or intrauterine resorption of a formed lens (secondary)
Patient Presentation	Neonate with absent or abnormal red reflex, poor visual fixation/tracking, nystagmus developing in early weeks of life
Classic Physical Exam	Absent lens on slit-lamp exam, flat anterior chamber (primary) or deepened anterior chamber (secondary), associated microphthalmia, sclerocornea
Key Diagnostic Results	Slit-lamp biomicroscopy showing no lens, ultrasound biomicroscopy (UBM) confirming absent lens and evaluating anterior segment anatomy, B-scan ultrasonography showing reduced axial length
Management	Immediate optical rehabilitation with aphakic contact lenses, aggressive amblyopia therapy, secondary IOL implantation considered when the eye matures
Keywords	"Absent red reflex in newborn," "no lens visible," "flat anterior chamber," "microphthalmia," "FOXE3 mutation," "neonatal nystagmus"

1. Pathophysiology

Congenital aphakia results from a developmental failure in lens morphogenesis during embryonic life. The lens originates from the surface ectoderm overlying the optic vesicle. Around the fourth week of gestation, the optic vesicle induces thickening of the overlying ectoderm to form the lens placode, which then invaginates to create the lens vesicle. This vesicle eventually separates from the surface ectoderm and differentiates into the mature crystalline lens.

In primary congenital aphakia, the lens placode either fails to form entirely or fails to invaginate. Because no lens vesicle ever develops, downstream anterior segment structures that depend on lens-derived inductive signals also fail to differentiate normally. This explains why primary aphakia is almost always accompanied by severe anterior segment dysgenesis, including absence of the iris, corneal opacification (sclerocornea), and a characteristically flat or shallow anterior chamber since no lens is present to maintain the anatomical space. The eye is frequently microphthalmic because the lens plays a trophic role in overall globe growth.

The genetic basis is strongly linked to mutations in the FOXE3 transcription factor (chromosome 1p33), inherited in an autosomal recessive pattern. FOXE3 is essential for lens placode survival and proliferation. Homozygous loss-of-function mutations lead to complete aplasia of the lens.

In secondary congenital aphakia, the lens initially forms but undergoes spontaneous resorption in utero due to intrauterine inflammation, infection, or idiopathic degeneration. Because the lens was present during the critical window of anterior segment induction, the iris and angle structures are relatively better developed compared to the primary form. The anterior chamber in secondary aphakia tends to be deep rather than flat, which is a key distinguishing feature.

The absence of the lens from birth means there is no refractive power in the eye from the moment the visual system begins developing. This leads to severe sensory deprivation amblyopia if not corrected promptly, making early optical rehabilitation the cornerstone of management.

2. Classification and Clinical Manifestation

Type	Mechanism	Anterior Chamber	Anterior Segment	Globe Size	Associated Findings
Primary Aphakia	Lens placode fails to form or invaginate; no lens vesicle ever exists	Flat/shallow	Severe dysgenesis: absent or rudimentary iris, sclerocornea, angle anomalies	Microphthalmic	Often bilateral, FOXE3 mutations, poor visual prognosis due to extensive structural anomalies
Secondary Aphakia	Lens forms normally but resorbs in utero	Deep	Relatively preserved; iris and angle structures present	Variable, may be near-normal	May be unilateral, residual lens capsule remnants may be visible, better structural prognosis

Manifestation by Age

Timing	Manifestation
At birth	Absent or white red reflex on newborn screening, visible corneal clouding (sclerocornea), obvious microphthalmia in primary type
First weeks	Poor visual fixation and tracking, lack of social smile response to faces
6 to 12 weeks	Development of sensory nystagmus indicating prolonged visual deprivation
Older infant	Strabismus, failure to reach for objects, developmental delay in visually guided milestones

3. Diagnostic Workup

Test	Role	Key Findings
Red reflex testing	Newborn screening (best initial test)	Absent or abnormal reflex prompts urgent referral
Slit-lamp biomicroscopy	Clinical confirmation	No crystalline lens in the pupillary area; assess iris, cornea, and anterior segment
Ultrasound biomicroscopy (UBM)	Most accurate test for anterior segment evaluation	Confirms absence of lens and lens capsule, differentiates primary from secondary (residual capsule fragments in secondary), maps anterior segment anatomy
B-scan ultrasonography	Posterior segment and globe assessment	Measures axial length (shortened in microphthalmia), rules out posterior segment pathology such as persistent fetal vasculature or retinal detachment
A-scan biometry	Preoperative planning	Determines axial length for future IOL power calculation
Genetic testing (FOXE3)	Etiologic confirmation and counseling	Homozygous or compound heterozygous mutations confirm primary aphakia; guides family counseling

The diagnostic pathway begins with newborn red reflex screening, which is the best initial test and should be performed on every neonate before discharge. An absent or grossly abnormal red reflex mandates urgent ophthalmologic referral within days.

Slit-lamp examination under sedation or general anesthesia (examination under anesthesia, or EUA) is the next step. The examiner looks for the absence of a crystalline lens behind the pupil, evaluates the corneal clarity, iris structure, and anterior chamber depth. In primary aphakia, the anterior chamber is notably flat with absent or poorly formed iris tissue. In secondary aphakia, the chamber is deep, and remnants of the lens capsule may be faintly visible.

Ultrasound biomicroscopy is the most accurate test for characterizing the anterior segment because it provides high-resolution cross-sectional imaging at frequencies of 35 to 50 MHz. UBM can definitively confirm that no lens or lens capsule exists (primary) versus demonstrate residual capsular material (secondary). This distinction has prognostic and surgical planning implications.

B-scan ultrasonography evaluates the posterior segment, which may be difficult to examine clinically if the cornea is opaque. It identifies associated anomalies such as persistent fetal vasculature, vitreous abnormalities, or retinal detachment, all of which affect visual prognosis.

Genetic testing for FOXE3 mutations is not required for clinical diagnosis but is valuable for confirming the etiology, predicting recurrence risk in siblings, and counseling parents regarding the autosomal recessive inheritance pattern.

4. Management and Treatment

Phase	Intervention	Details
Immediate (first weeks)	Aphakic contact lenses	High-plus silicone elastomer or rigid gas-permeable lenses; power typically +20 D to +30 D depending on axial length; fitted as early as the first week of life
Ongoing (infancy)	Amblyopia therapy	If unilateral or asymmetric, patching of the better eye for 1 to 2 hours per day in young infants, gradually increased based on response; atropine penalization as alternative
Supportive	Aphakic spectacles	Used as backup or supplement, though poor cosmesis and optical distortion (magnification, ring scotoma) limit utility in children
Surgical (older child)	Secondary IOL implantation	Considered around age 2 or older when the eye has grown sufficiently and accurate biometry is feasible; sulcus-fixated or scleral-fixated IOL since there is no capsular support
Associated pathology	Glaucoma management	Frequent monitoring of intraocular pressure; medical therapy (timolol, dorzolamide) first line; surgical intervention (goniotomy, trabeculotomy, or tube shunt) if refractory
Long-term	Low vision rehabilitation	Visual aids, educational accommodations, lifelong follow-up

The cornerstone of treatment is early and aggressive optical correction to prevent irreversible amblyopia. The critical period for visual development extends through the first several years of life, with the highest sensitivity in the first few months. Every week of delay without optical correction during this window worsens the long-term visual outcome.

Aphakic contact lenses are the preferred initial modality because they provide a full visual field, minimal magnification compared to spectacles, and are well tolerated in infants. Silicone elastomer lenses (extended wear) are commonly chosen for neonates because they can be worn continuously and require less frequent handling. Lens power is determined by retinoscopy and is typically in the range of +20 D to +30 D for the neonatal eye. As the eye grows and the refractive error changes, frequent refraction (every 1 to 2 months in the first year) and lens power adjustments are necessary.

Amblyopia therapy is critical, especially in unilateral cases where the fellow eye will preferentially develop cortical dominance. Patching protocols follow standard amblyopia guidelines, with the duration titrated to age and severity. In bilateral aphakia, both eyes are corrected simultaneously, and patching is used only if there is asymmetry in visual development.

Secondary IOL implantation is deferred until the eye reaches sufficient size and the refraction stabilizes enough for accurate lens power calculation. Because no natural capsular bag exists, the IOL must be fixated to the ciliary sulcus or sclera using sutures or glue. This carries higher surgical complexity and complication risk (IOL tilt, decentration, vitreous hemorrhage, retinal detachment) compared to standard in-the-bag implantation. Timing is individualized but generally considered after age 2.

Patients with congenital aphakia, particularly the primary form, are at elevated risk for secondary glaucoma due to associated angle dysgenesis. Intraocular pressure must be monitored at every visit. Medical therapy is the first approach, but surgical drainage procedures are frequently required.

5. Differential Diagnosis and Distractors

Differential Diagnosis	Why It Is Similar	Key Discriminator
Dense congenital cataract	Both present with absent or white red reflex in neonate; both cause deprivation amblyopia	In cataract, the lens is present but opacified; slit-lamp and UBM show a lens structure. In aphakia, no lens exists at all
Peters anomaly	Central corneal opacity with anterior segment dysgenesis; can be associated with lens abnormalities	Peters anomaly has a central corneal leukoma with iridocorneal adhesions; the lens may be adherent to the posterior cornea but is present. In aphakia, no lens is found
Persistent fetal vasculature (PFV)	Leukocoria in a newborn with microphthalmic eye	PFV shows a retrolental fibrovascular membrane with a stalk from the optic disc; the lens is present (though often cataractous). Ultrasound distinguishes the two
Retinoblastoma	Leukocoria in infant; urgent concern on any abnormal red reflex	Retinoblastoma shows an intraocular mass on ultrasound with intrinsic calcification; the lens is present and typically clear. Fundoscopy and imaging are diagnostic
Lens subluxation (ectopia lentis)	Lens may not be visible in the pupillary axis, mimicking aphakia	In subluxation, the lens edge is visible when the pupil is dilated; the lens is displaced but present. Associated with Marfan syndrome or homocystinuria
Aniridia	Shared anterior segment dysgenesis features, FOXE3 overlap in differential	Aniridia has absent iris but the lens is present (though often with progressive cataract). Caused by PAX6 mutations, not FOXE3

6. Traps and High-Yield Pearls

The most common mistake students make with congenital aphakia is confusing it with a dense congenital cataract. Both present with an absent red reflex in the newborn period, and both require urgent intervention to prevent amblyopia. The critical distinction is whether a lens structure exists at all. When a vignette describes a neonate with leukocoria and slit-lamp or ultrasound findings showing no lens whatsoever (rather than an opacified lens), the answer is aphakia, not cataract. If the stem mentions a "flat anterior chamber" alongside absent lens, this further points to primary aphakia rather than a resorbed cataract.

A second trap involves the anterior chamber depth. Students who memorize "aphakia equals deep chamber" from adult/surgical aphakia will be misled. In congenital primary aphakia, the chamber is flat because the entire anterior segment is dysgenetic. The deep chamber presentation applies to secondary congenital aphakia and to acquired (surgical) aphakia. Pay close attention to whether the vignette describes associated anterior segment anomalies (flat chamber, sclerocornea, iris hypoplasia) versus a structurally intact eye missing only the lens.

The core competency being tested is the ability to recognize a neonatal presentation of absent red reflex, systematically work through the differential for leukocoria, and identify the distinguishing features that separate aphakia from its mimics. Secondary to this is understanding that timing of optical correction determines visual outcome, making this a diagnosis where the "next best step" after confirmation is always immediate contact lens fitting, not watchful waiting or surgical planning.

1e:["$","$L2d",null,{"article":{"id":"a31c222c-3ee0-4714-b440-da2ed3e77836","title":"Afakia Kongenital","content":"$2e","category":"Oftalmologi","created_at":"2026-05-13T11:28:55.588487+00:00","status":"published","subcategory":null},"questionCount":0,"sections":[{"id":"section-pathophysiology","num":"01","title":"Pathophysiology"},{"id":"section-classification-and-clinical-manifestation","num":"02","title":"Classification and Clinical Manifestation"},{"id":"section-diagnostic-workup","num":"03","title":"Diagnostic Workup"},{"id":"section-management-and-treatment","num":"04","title":"Management and Treatment"},{"id":"section-differential-diagnosis-and-distractors","num":"05","title":"Differential Diagnosis and Distractors"},{"id":"section-traps-and-high-yield-pearls","num":"06","title":"Traps and High-Yield Pearls"}],"hasSummaryTable":true}]